16. November 2009 09:04
Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, announced today that Lysteda(TM) (tranexamic acid) oral tablets has received U.S. Food and Drug Administration (FDA) approval for treatment of women suffering from cyclic heavy menstrual bleeding (HMB), also known as menorrhagia.
[More]
9. November 2009 08:50
In their American Society of Reproductive Medicine (ASRM) conference wrap-up, Medscape highlighted the article published by them on October 27, 2009, which summarized the results from the largest prospective, randomized clinical study to compare vaginal progesterone to intramuscular progesterone injections (IM progesterone) for luteal support in infertility treatment.
[More]
eae6ffa9-f485-4ce6-8179-2b0c8cd4ba70|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Abortion, Constipation, Endocrinology, Exercise, Fertility, Headache, Hospital, Infertility, IVF, Menstruation, Nausea, Obstetrics, Ovulation, Pregnancy, Progesterone, Testosterone, Ultrasound
6. November 2009 06:36
Are you a female athlete - or just someone who likes challenging workouts -- who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
[More]
23. October 2009 01:40
A prospective, multi-center study demonstrated that in IVF (in vitro fertilization) cycles supplemented with once-daily dosing of Crinone® vaginal progesterone gel and Estrace® oral estrogen, vaginal bleeding is rare in patients who become pregnant. Bleeding does occur in approximately one-quarter of patients who do not become pregnant. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
[More]
4d50c8be-bf48-4582-aa2f-ff4809eb19f7|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Abortion, Constipation, Endocrinology, Estradiol, Estrogen, Headache, Infertility, IVF, Menstruation, Nausea, Ovulation, Pregnancy, Progesterone, Stress, Testosterone
21. October 2009 04:06
A retrospective analysis, conducted at a large infertility clinic between January 2003 and December 2008, demonstrated that there were no significant differences in pregnancy outcomes with three different progesterone formulations for women aged 35 to 40 undergoing in vitro fertilization-embryo transfer (IVF-ET) procedures. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.
[More]
b9c8ff9d-8f6b-4b09-b5a1-fc84de1d1613|0|.0
Posted in: Women's Health News | Pharmaceutical News
Tags: Abortion, Constipation, Endocrinology, Headache, Infertility, IVF, Menstruation, Nausea, Ovulation, Pregnancy, Progesterone, Testosterone
6. October 2009 07:59
Vantia Therapeutics today announces that its novel oral small molecule drug for the treatment of dysmenorrhoea (painful menstruation) has entered Phase II proof-of-concept trials. In addition, Vantia announces results of the successful Phase I trial of VA111913, which showed the product candidate to be safe and well tolerated.
[More]
3. October 2009 02:06
The U.S. Food and Drug Administration today approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. This is the first intrauterine device approved by the FDA for this additional indication.
[More]
22. September 2009 00:41
While most women experience minor pain during menstruation, for others, the pain can be severe enough to interfere with everyday activities and require medication. New research to be presented at the 2009 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition will reveal initial findings of safety surrounding a new device that may more effectively treat menstrual pain.
[More]
11. September 2009 05:38
Merck & Co., Inc. today updated the status of the clinical development programs for telcagepant (MK-0974) and MK-3207, the Company's investigational oral calcitonin gene-related peptide (CGRP) receptor antagonists for the intermittent treatment of acute migraine.
[More]
ba974475-c2e8-4c7b-b1c1-faaf1f8c892e|0|.0
Posted in: Drug Trial News
Tags: Abdominal Pain, Acid Reflux, Acne, Angina, Angioedema, Anorexia, Anxiety, Arrhythmia, Arthralgia, Blood Pressure, Blood Vessel, Bone, Bone Marrow, Brain, Caffeine, Calcitonin, Calcium, Cardiovascular Disease, Cell, Cholesterol, Cirrhosis, Citalopram, Constipation, Contraception, Coronary Artery Disease, Cough, Creatinine, Cymbalta, Dehydration, Depression, Diabetes, Dialysis, Diarrhea, Diet, Digestive System, Drug Abuse, Duloxetine, Dyspnea, Edema, Fertility, Gastritis, Headache, Hospital, Hypercholesterolemia, Hypersensitivity, Incontinence, Insomnia, Lexapro, Menopause, Menstruation, Metabolism, Migraine, Nausea, Nervous System, Nursing, Obesity, Olanzapine, Paralysis, Pharmacology, Pregnancy, Prophylaxis, Serotonin, Sleep, Smoking, Speech, Stress, Stroke, Tinnitus, Transient Ischemic Attack, Urticaria, Venlafaxine, Vomiting, Zoloft
2. September 2009 06:18
A surgical procedure known as LUNA (laparoscopic uterosacral nerve ablation) did not result in improvements in chronic pelvic pain, painful menstruation, painful sexual intercourse or quality of life when compared with laparoscopic surgery that does not interrupt pelvic nerve connections, according to a study in the September 2 issue of JAMA.
[More]
27. August 2009 03:40
Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.
[More]
10. August 2009 19:14
Women with a family history of breast cancer appear to have a lower risk of developing the disease before menopause if they have ever breastfed a child, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
[More]
9. July 2009 16:07
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
[More]
7. July 2009 20:01
Chinese herbal medicine (CHM) may relieve symptoms in the treatment of endometriosis. A systematic review by Cochrane Researchers found some evidence that women had comparable benefits following laparoscopic surgery and suffered fewer adverse effects if they were given Chinese herbs compared with conventional drug treatments.
[More]
23. June 2009 19:30
Robot-assisted surgery can be used to successfully repair abnormal openings between the uterus and the bladder, according to a report by Ashok K. Hemal, M.D., a Wake Forest University Baptist Medical Center urologist who is the world's most experienced surgeon in the procedure.
[More]